Keri Messina
Adult Health · Greenvale, NYNPI 1154848026
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 300 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Abbott accounts for 60.9% of it on its own, with 24 other manufacturers making up the rest. Reporting peaked in 2023 at $3,516 and has fallen 52.0% since, to $1,686 in 2025. Among adult health clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 300 payments — averaging $34.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$6K
- Alnylam Pharmaceuticals Inc.$733
- AstraZeneca$689
- Novartis$514
- Boehringer Ingelheim$361
- Actelion Pharmaceuticals US, Inc.$327
- plus $1K from 19 others
What the payments were for
- Food & beverage$10,368100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 124 | $6,318 |
| Alnylam Pharmaceuticals Inc. | 42 | $733 |
| AstraZeneca | 30 | $689 |
| Novartis | 25 | $514 |
| Boehringer Ingelheim | 15 | $361 |
| Actelion Pharmaceuticals US, Inc. | 16 | $327 |
| Galderma Laboratories, L.p. | 3 | $243 |
| Merck | 9 | $184 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $170 |
| AbbVie | 1 | $149 |
| Vifor Pharma, Inc. | 6 | $121 |
| Scpharmaceuticals Inc. | 4 | $110 |
| Bayer | 4 | $85 |
| Akcea Therapeutics, Inc. | 3 | $63 |
| Abiomed | 2 | $49 |
| Impulse Dynamics (USA) Inc. | 2 | $46 |
| Kestra Medical Technology Services, Inc. | 2 | $43 |
| Daxor Corporation | 1 | $25 |
| Novo Nordisk | 1 | $25 |
| Medtronic | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $20 |
| United Therapeutics Corporation | 1 | $19 |
| Bridgebio Pharma, Inc. | 1 | $18 |
| Lexicon Pharmaceuticals, Inc. | 1 | $17 |
| Boston Scientific | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,368 in reported general payments places this provider in the 95th percentile of 3,828 adult health providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sildenafil Citrate | 12 | $19,890 |
| Amiodarone Hcl | 26 | $2,289 |
| Warfarin Sodium | 45 | $1,497 |
| Bumetanide | 21 | $1,496 |
| Metoprolol Succinate | 22 | $681 |
| Pantoprazole Sodium | 30 | $475 |
| Digoxin | 17 | $350 |
| Famotidine | 18 | $325 |
| Tamsulosin Hcl | 17 | $247 |
| Carvedilol | 12 | $245 |
| Atorvastatin Calcium | 14 | $241 |
| Allopurinol | 18 | $177 |
| Torsemide | 17 | $168 |
| Losartan Potassium | 11 | $71 |
Paid to pharmacies, not to this prescriber.
Other adult health in Greenvale
- Donna CatameroNew York$279K
- Kristen DurkinPort Jefferson Station$255K
- Mary CiechoskiBuffalo$200K
- Jennifer FioriniGlens Falls$151K
- Katelyn McCormackAmherst$131K
- Maria Gigante-BaggettEast Syracuse$92K
- Jane PattersonRochester$66K
- Alyson HartyNew York$65K
- Danielle BrunoPlainview$61K
- Julie PlantamuraPort Jefferson Station$60K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.